SecBot SecBot

SEER

Seer, Inc.
Nasdaq· Laboratory Analytical Instruments· Inc. DE· CIK 0001726445 Industrials & Manufacturing
$1.96 +0.03 (+1.55%)
Oct 27 4:00 PM ET · prev $1.93
Market cap
$109.1M
Micro cap
Median target
$4.00
+104% · range $4.00–4.00
Next earnings
Nov 10
in 14 days · EPS est. −$0.26
1 year
−17.3%
from $2.37 · Oct 27
30 days
−3.4%
from $2.03
52-week range
$1.62–2.37
−17% from high · low Jul 2
Avg volume 20D
222.3K
Sep 30 spike 752.5K
Short interest
🔒 Subscribers only
Insider net
−$50.4K
0 buyers · 2 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
33
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 0 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 4/5 ·Next Earnings date, Nov 10, 2026
Strongest NEUTRAL The USITC has found the sole respondent, Nanomics Biotechnology Co., Ltd., in default in Investigation No…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $50.4K.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 3 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.240 → −$0.260 over 90 days. 0 up, 2 down in 30 days.

  • TrendRANGE

    3% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GOLDMAN SACHS GROUP INCADD246,638$409.4K
JACOBS LEVY EQUITY MANAGEMENT, INCADD222,332$369.1K
NORTHERN TRUST CORPTRIM78,895$131.0K
PRICE T ROWE ASSOCIATES INC /MD/ADD51,914$87.0K
UBS Group AGTRIM26,139$43.4K
BARCLAYS PLCNEAR_EXIT8,127$13.5K
JACOBS LEVY EQUITY MANAGEMENT, INCDOUBLED143,242$240.6K
Point72 Asset Management, L.P.TRIM14,813$24.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +104%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
May 4, 2026Canaccord Genuity
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$50.4K
sold · 2 insiders
DateInsiderTypeValue
Aug 18, 2026
Horn David R.
PRESIDENT & CFO
SELL$14.8K
Jul 28, 2026
MCGUIRE TERRANCE
Director
AWARD16,500 sh
Jul 28, 2026
MCGUIRE TERRANCE
Director
AWARD25,000 sh
Jul 28, 2026
Roelofs Nicolas H PHD
Director
AWARD25,000 sh
Jul 28, 2026
Roelofs Nicolas H PHD
Director
AWARD16,500 sh
Jul 28, 2026
LANGER ROBERT
Director
AWARD16,500 sh
Jul 28, 2026
LANGER ROBERT
Director
AWARD25,000 sh
Jul 28, 2026
Nishar Dipchand
Director
AWARD25,000 sh

Earnings setup

Estimates
Nov 10
reports in 14 days
−$0.26
EPS estimate, this quarter
−8%
estimate change, 90 days
0↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.26-$0.27–-$0.25+0.0%$4.2M
Next Q-$0.22-$0.23–-$0.21+0.0%$6.1M
Current FY-$1.10-$1.11–-$1.09+0.0%$16.1M
Next FY-$1.05-$1.09–-$1.02-3.4%$19.4M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Seer, Inc. announced it will report its Q3 2026 results on November 10, 2026.
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and t
Oct 15, 2026 SEC
The USITC has found the sole respondent, Nanomics Biotechnology Co., Ltd., in default in Investigation No…
ITC-337 — Impact 4/10
Oct 8, 2026 SEC
Charles Endweiss filed a Form 3 initial statement of beneficial ownership upon becoming VP of Financial Planning &…
3 — Impact 2/10
Sep 21, 2026 Press
Seer, Inc. announced that President, CFO and Treasurer David Horn will depart effective October 1, 2026, to pursue an…
Impact 3/10
Aug 18, 2026 Insider
Horn David R. sold 7,309 shares
PRESIDENT & CFO @ $2.03 ($14.8K)
Jul 28, 2026 Insider
MCGUIRE TERRANCE was granted 16,500 shares
Director
Jul 28, 2026 Insider
MCGUIRE TERRANCE was granted 25,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
SEER Q3 2026 Earnings Scheduled — 2026-11-10
Recent
Oct 21, 2026
Earnings
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic…
Oct 15, 2026
Itc 337
ITC 337-TA-1508: Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins — Notice of Commission Determination Not To Review an Initial Determination Finding the Sole Respondent in This Investigation in Default; Request for Written Submissions on Remedy, the Public Interest, and Bonding
Complainant(s): Seer, Inc.. Respondent(s): Nanomics Biotechnology Co., Ltd..
Sep 21, 2026
Leadership
Seer Announces CFO Transition
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for…
Sep 16, 2026
Press release
Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence…
Aug 11, 2026
Earnings date
SEER Q2 2026 Earnings Scheduled — 2026-08-11

SecBot reports

33 filings · 5 press releases · 11 bullish · 4 bearish · 7 mixed · 11 neutral
All SEER filing & press-release reports (38)